BLKB Director Granted 3,670 Restricted Shares in Form 4 Filing
On 08/01/2025, Blackbaud, Inc. (BLKB) director Bradley L. Pyburn disclosed the award of 3,670 restricted shares of common stock at no cost (Form 4 transaction code “A”) in a filing dated 08/05/2025.
Rhea-AI Filing Summary
On 08/01/2025, Blackbaud, Inc. (BLKB) director Bradley L. Pyburn disclosed the award of 3,670 restricted shares of common stock at no cost (Form 4 transaction code “A”) in a filing dated 08/05/2025. Following the grant, Pyburn’s direct ownership rises to 5,269 shares.
The award will vest on 08/01/2026, or immediately before Blackbaud’s 2026 annual director election if earlier, provided he remains a director. No derivative positions or dispositions were reported, indicating a routine equity-based board compensation event with negligible dilution.
Positive
- Increased insider ownership aligns director incentives with shareholder value, albeit at a small scale.
Negative
- None.
Insights
TL;DR: Routine director grant; minor share count; neutral financial impact, modest governance alignment.
This Form 4 records a standard equity retainer for outside director Bradley L. Pyburn. The 3,670-share grant represents an immaterial fraction of Blackbaud’s float and adds only 1,599 net shares to his holdings, lifting total ownership to 5,269 shares. Vesting is service-based, so the award modestly tightens director-shareholder alignment without cash outlay. Absence of sales or option exercises signals no negative insider sentiment. From a valuation perspective, dilution is de minimis; therefore, the filing is not materially impactful to investors, though governance observers may view the additional skin-in-the-game positively.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,670 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents a restricted stock award, all of which shall vest on August 1, 2026 or, if earlier, immediately prior to the 2026 annual election of directors of the Company, provided that the reporting person is then serving as a director of the Company.
FAQ
What was the transaction date for the BLKB Form 4 filing?
Were any derivative securities or sales reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.